Bivalirudin versus heparin in patients undergoing percutaneous peripheral interventions: A systematic review and meta-analysis.
Wilman OlmedoPedro A VillablancaCristina SaninaJonathan WalkerMichael WeinreichJeannine BrevikRicardo AvendanoClaudio A BravoJorge RomeroHarish RamakrishnaAnvar BabaevMichael AttubatoDagmar F Hernandez-SuarezP Cox-AlomarRobert PyoPrakash KrishnanJose WileyPublished in: Vascular (2018)
Our meta-analysis suggests that bivalirudin use for percutaneous peripheral interventions is associated with lower all-cause mortality, bleeding, and access site complications as compared to heparin. Further large randomized trials are needed to confirm the current results.